We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genosis | LSE:GNOS | London | Ordinary Share | GB00B0NVFD79 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.125 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 1079W Genosis PLC 06 June 2008 6 June 2008 For Immediate Release Genosis PLC ("the Company") Proposed Delisting from AIM Genosis PLC (AIM - GNOS) today announces that it intends to seek shareholder approval to cancel admission of the ordinary shares of 10p each in the Company ("Ordinary Shares") to trading on AIM and re-register the Company as a private company ("the Proposals"). A circular containing details of the Proposals has been sent to shareholders today and copies will be available from the Company's website, www.genosis.com. Over the past year, the Directors have attempted to expand the business of the Company through launching its only product in the United States. The sales of the product have been disappointing and as a consequence the Directors announced in September 2007 that they would carry out a strategic review to determine the future direction of the Company. In April 2008 the Directors announced that they wished to dispose of the Company or its assets as they felt that this would be the best approach to maintaining shareholder value. To achieve this objective the Directors consider that it would be in the best interests of the Company to de-list from AIM. The market has not recognised the value of the remaining assets of the Company, notably its Intellectual Property, current assets and its tax losses. The Directors also consider that the cost of being a public company, in the region of £150,000 per annum, cannot be justified. Given the low market capitalisation of the Company, the low liquidity of the Ordinary Shares and the requirement to conserve cash, the Directors consider that it would be in the interests of the Company to seek a delisting of its shares from AIM. Under the AIM Rules, it is a requirement that any delisting from AIM must be approved by not less than 75 per cent. of shareholders voting in a general meeting. Accordingly, an Extraordinary General Meeting ("EGM") has been convened, at which a special resolution to approve the cancellation of admission of the Company's shares on AIM, and the re-registration of the Company as a private company, will be proposed. The EGM will be held at 10.00 a.m. on 30 June 2008 at the Company's offices, 1 Crown Square, Woking, Surrey, GU21 6HR. If the resolution is approved, it is expected that cancellation of dealings will take effect at 7.00 a.m. on 8 July 2008. The Directors are aware that shareholders of the Company may still wish to acquire further shares or dispose of their shares and, accordingly, intend to use reasonable endeavours to create and maintain a matched bargain settlement facility. This facility would be managed by the Company and details of its operation will be made available on the Company's website after the EGM. Enquiries: Genosis plc Tel: +44 (0) 1483 774 050 Paul Bateman, Chief Executive Officer Jonathan Pockson, Chief Financial Officer Evolution Securities Tel: +44 (0) 207 071 4300 Bobbie Hilliam/ Chris Clarke Buchanan Communications Tel: +44 (0) 207 466 5000 Lisa Baderoon This information is provided by RNS The company news service from the London Stock Exchange END MSCUUUACQUPRGAA
1 Year Genosis Chart |
1 Month Genosis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions